dianhydrogalactitol has been researched along with Carcinoma, Squamous Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylouny, RA; Bissell, EC; Holiat, SM; Hubert, DD; Smith, WE; Sobel, HJ; Watts, LM; Yazdi, E | 1 |
| Bakowski, MT; Crouch, JC | 1 |
| Barranco, SC; Costanzi, JJ; O'Quinn, AG | 1 |
| Blessing, JA; Blom, J; Ehrlich, CE; Mangan, C; Stehman, FB | 1 |
| Calanog, A; Camacho, F; Seltzer, V; Vogl, SE | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Creagan, ET; Eagan, RT; Fleming, TR; Frytak, S; Ingle, JN; Kvols, LK | 1 |
| Baltz, R; Barranco, SC; Boerwinkle, WR; Costanzi, JJ; Guseman, LF; Hokanson, KM; Leipzig, B; May, JT; O'Quinn, AG; Townsend, CM | 1 |
| Creagan, ET; Eagan, RT; Kvols, LK | 1 |
1 review(s) available for dianhydrogalactitol and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
2 trial(s) available for dianhydrogalactitol and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Dianhydrogalactitol; Doxorubicin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Time Factors; Vomiting | 1980 |
7 other study(ies) available for dianhydrogalactitol and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
Topics: Animals; Antineoplastic Agents; Asbestos, Serpentine; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mitoxantrone; Models, Animal; Nitrosourea Compounds; Pentostatin; Remission Induction; Survival Analysis; Triazines | 2005 |
Tumor cell kinetics-directed chemotherapy for advanced squamous carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Cycle; Dianhydrogalactitol; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1984 |
Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms | 1983 |
Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
Topics: Aged; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Sugar Alcohols; Uterine Cervical Neoplasms | 1982 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
Topics: Adenocarcinoma; Biopsy; Carcinoma, Squamous Cell; Cell Cycle; Dianhydrogalactitol; Drug Administration Schedule; Humans; Kinetics; Melanoma; Neoplasms; Sugar Alcohols | 1982 |
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
Topics: Brain Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pilot Projects; Podophyllotoxin; Sugar Alcohols | 1981 |